Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple versus dual inhaled therapy in uncontrolled asthma
2021-002391-39Phase 4Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of beclometasone dipropionate + formoterol and glycopyrronium in asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Started Sep 2021; status: completed.
02
Drugs
beclometasone dipropionate + formoterolglycopyrronium
03
Conditions
asthma
Beyond the preview
Go deeper on 2021-002391-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002391-39.